The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure

Some pathogens (e.g., Mycobacterium tuberculosis, Toxoplasma gondii, Leishmania spp) have been shown to persist in their host after clinical cure, establishing the risk of disease reactivation. We analyzed the conditions necessary for the long term maintenance of Leishmania major in genetically resistant C57BL/6 mice after spontaneous healing of their dermal lesions. Interleukin (IL)-10 was found to play an essential role in parasite persistence as sterile cure was achieved in IL-10–deficient and IL-4/IL-10 double-deficient mice. The requirement for IL-10 in establishing latency associated with natural infection was confirmed in IL-10–deficient mice challenged by bite of infected sand flies. The host-parasite equilibrium was maintained by CD4+ and CD8+ T cells which were each able to release IL-10 or interferon (IFN)-γ, and were found to accumulate in chronic sites of infection, including the skin and draining lymph node. A high frequency of the dermal CD4+ T cells released both IL-10 and IFN-γ. Wild-type mice treated transiently during the chronic phase with anti–IL-10 receptor antibodies achieved sterile cure, suggesting a novel therapeutic approach to eliminate latency, infection reservoirs, and the risk of reactivation disease.

[1]  Yong‐jun Liu,et al.  Anti–Interleukin 10 Receptor Monoclonal Antibody Is an Adjuvant for T Helper Cell Type 1 Responses to Soluble Antigen Only in the Presence of Lipopolysaccharide , 2000, The Journal of experimental medicine.

[2]  Y. Belkaid,et al.  Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. , 2000, Science.

[3]  A. Enk,et al.  Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells , 2000, The Journal of experimental medicine.

[4]  J. Bluestone,et al.  Evidence for Functional Relevance of CTLA-4 in Ultraviolet-Radiation-Induced Tolerance1 , 2000, The Journal of Immunology.

[5]  N. Glaichenhaus,et al.  The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Scott,et al.  IL-12 Is Required to Maintain a Th1 Response During Leishmania major Infection1 , 2000, The Journal of Immunology.

[7]  Y. Belkaid,et al.  A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity , 2000, The Journal of Immunology.

[8]  C. Bogdan,et al.  Fibroblasts as Host Cells in Latent Leishmaniosis , 2000, The Journal of experimental medicine.

[9]  T. Nutman,et al.  IL-12p70 Production by Leishmania major-Harboring Human Dendritic Cells Is a CD40/CD40 Ligand-Dependent Process , 2000, The Journal of Immunology.

[10]  G. Milon,et al.  Distinct Innate and Acquired Immune Responses to Leishmania in Putative Susceptible and Resistant Human Populations Endemically Exposed to L. (Viannia) panamensis Infection , 2000, Scandinavian journal of immunology.

[11]  M. Leach,et al.  Chronic Colitis in IL-10-/- Mice: Insufficient Counter Regulation of a Th1 Response , 2000, International reviews of immunology.

[12]  F. Powrie,et al.  Regulatory T cells and inflammatory bowel disease. , 1999, Immunology today.

[13]  G. Trinchieri,et al.  CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .

[14]  T. Wynn,et al.  Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. , 1999, Journal of immunology.

[15]  A. Hill,et al.  Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. , 1999, Immunity.

[16]  R. Coffman,et al.  Experimental Leishmania major infection in mice: role of IL‐10 , 1999, Parasite immunology.

[17]  M. Roncarolo,et al.  A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.

[18]  G. Trinchieri,et al.  CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. , 1999, Clinical immunology.

[19]  Y. Belkaid,et al.  Development of a Natural Model of Cutaneous Leishmaniasis: Powerful Effects of  Vector Saliva and Saliva Preexposure on the Long-Term Outcome of Leishmania major Infection in the Mouse Ear Dermis , 1998, The Journal of experimental medicine.

[20]  Yasmine Belkaid,et al.  Uptake of Leishmania major Amastigotes Results in Activation and Interleukin 12 Release from Murine Skin–derived Dendritic Cells: Implications for the Initiation of Anti-Leishmania Immunity , 1998, The Journal of experimental medicine.

[21]  W. Degrave,et al.  Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. , 1998, The Journal of infectious diseases.

[22]  K. Dellagi,et al.  Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. , 1998, The Journal of infectious diseases.

[23]  A. Steere,et al.  Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. , 1998, Journal of immunology.

[24]  Y. Liu,et al.  IL‐10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3‐dependent and ‐independent pathways , 1998, The EMBO journal.

[25]  T. Theander,et al.  High levels of plasma IL‐10 and expression of IL‐10 by keratinocytes during visceral leishmaniasis predict subsequent development of post‐kala‐azar dermal leishmaniasis , 1998, Clinical and experimental immunology.

[26]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[27]  T. Jakob,et al.  E-cadherin-mediated adhesion involving Langerhans cell-like dendritic cells expanded from murine fetal skin. , 1997, Journal of immunology.

[28]  R. Locksley,et al.  Altered Immune Responses in Interleukin 10 Transgenic Mice , 1997, The Journal of experimental medicine.

[29]  P. Guevara,et al.  Persistent infections by Leishmania (Viannia) braziliensis. , 1997, Memorias do Instituto Oswaldo Cruz.

[30]  R. López-Vélez,et al.  Leishmania and human immunodeficiency virus coinfection: the first 10 years , 1997, Clinical microbiology reviews.

[31]  G. Trinchieri,et al.  Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10 , 1996, The Journal of experimental medicine.

[32]  C. Bogdan,et al.  Murine epidermal Langerhans cells do not express inducible nitric oxide synthase , 1996, European journal of immunology.

[33]  C. Bogdan,et al.  Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase , 1996, The Journal of experimental medicine.

[34]  R. Badolato,et al.  Promastigotes Selectively Inhibit Interleukin 12 Induction in Bone Marrow-derived Macrophages from Susceptible and Resistant Mice , 1996 .

[35]  F. Nestle,et al.  Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. , 1995, Journal of immunology.

[36]  H. Moll,et al.  Dendritic cells seclude Leishmania parasites that persist in cured mice--a role in the maintenance of T-cell memory? , 1995, Advances in experimental medicine and biology.

[37]  M. Vieth,et al.  Interleukin‐10 Inhibits Antimicrobial Activity Against Leishmania major in Murine Macrophages , 1994, Scandinavian journal of immunology.

[38]  A. Momeni,et al.  CLINICAL PICTURE OF CUTANEOUS LEISHMANIASIS IN ISFAHAN, IRAN , 1994, International journal of dermatology.

[39]  Darnell,et al.  Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis , 1994, Infection and immunity.

[40]  E. Handman,et al.  Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host , 1993, Infection and immunity.

[41]  I. Müller.  Role of T cell subsets during the recall of immunologic memory to Leishmania major , 1992, European journal of immunology.

[42]  E. Zijlstra,et al.  Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[43]  A. Sher,et al.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.

[44]  G. Tosato,et al.  IL-10 inhibits human T cell proliferation and IL-2 production. , 1992, Journal of immunology.

[45]  G. Gallagher,et al.  Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL‐2 or IL‐4 is species and time dependent , 1992, Parasite immunology.

[46]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[47]  T. Mosmann,et al.  The role of IL-10 in crossregulation of TH1 and TH2 responses. , 1991, Immunology today.

[48]  R. Locksley,et al.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism , 1990, The Journal of experimental medicine.

[49]  J. Louis,et al.  Analysis of the Cellular Parameters of the Immune Responses contributing to Resistance and Susceptibility of Mice to Infection with the Intracellular Parasite, Leishmania major , 1989, Immunological reviews.

[50]  J. Louis,et al.  Immunity to experimental infection with Leishmania major: generation of protective L3T4+ T cell clones recognizing antigen(s) associated with live parasites , 1989, European journal of immunology.

[51]  T. Boon,et al.  A limiting dilution assay for quantifying Leishmania major in tissues of infected mice , 1985, Parasite immunology.

[52]  Á. Holguín,et al.  Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. , 1985, The American journal of tropical medicine and hygiene.